Cargando…

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?

Levetiracetam is a commonly prescribed antiepileptic agent and has rarely been linked to hepatotoxicity. This case describes a patient with drug-induced autoimmune hepatitis secondary to levetiracetam.

Detalles Bibliográficos
Autores principales:	Hegazy, Yassmin, Axley, Page, Lee, Goo, Gray, Meagan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019274/ https://www.ncbi.nlm.nih.gov/pubmed/36936131 http://dx.doi.org/10.14309/crj.0000000000001003

Ejemplares similares

Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats
por: Al-Shorbagy, Muhammad Y., et al.
Publicado: (2013)

Liver Transplantation in Hepatitis B Reactivation in a Patient With Active HIV Viremia
por: Hegazy, Yassmin, et al.
Publicado: (2022)

A Rare Case of Drug-Induced Liver Injury Caused by Levetiracetam
por: Kawaguchi, Tomohiro, et al.
Publicado: (2019)

The antiepileptic drug levetiracetam improves auditory gating in DBA/2 mice
por: Smucny, Jason, et al.
Publicado: (2015)

Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
por: Zhang, Qirui, et al.
Publicado: (2018)

Severe drug-induced liver injury caused by levetiracetam – A case report and review of the literature
por: Rogalewski, Andreas, et al.
Publicado: (2021)

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
por: Hansen, Cerine C., et al.
Publicado: (2018)

Levetiracetam-induced pancytopenia
por: Alzahrani, Talal, et al.
Publicado: (2015)

Lacosamide and sodium channel‐blocking antiepileptic drug cross‐titration against levetiracetam background therapy
por: Baulac, M., et al.
Publicado: (2016)

Physiologically‐based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents
por: Sinha, Jaydeep, et al.
Publicado: (2021)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Severe Alcoholic Hepatitis: Atypical Presentation with Markedly Elevated Alkaline Phosphatase
por: Axley, Page, et al.
Publicado: (2017)

Presumed bilateral branch retinal vein occlusions secondary to antiepileptic agents
por: Hussain, Rumana N, et al.
Publicado: (2011)

Levetiracetam-induced transaminitis in a young male with traumatic brain injury
por: Rachamallu, Vivekananda, et al.
Publicado: (2017)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014)

Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
por: Sulsenti, Roberta, et al.
Publicado: (2021)

Levetiracetam-Induced Acute Psychosis in an Adolescent
por: Dhungel, Omkar, et al.
Publicado: (2023)

Levetiracetam Adverse Drug Reaction: Pancytopenia
por: Gohil, Jayendra R., et al.
Publicado: (2018)

Acute Liver Failure Associated with Levetiracetam and Lacosamide Combination Treatment for Unspecified Epileptic Disorder
por: Gutiérrez-Grobe, Ylse, et al.
Publicado: (2013)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

Hallucination: A rare complication of levetiracetam theraphy
por: Erdogan, Seher, et al.
Publicado: (2017)

A case of dyskinesia after levetiracetam administration
por: Yim, Soo Hwan, et al.
Publicado: (2019)

Levetiracetam induced hypomania: a case report
por: Altınöz, Ali Ercan, et al.
Publicado: (2019)

Multifocal myoclonus as a presentation of levetiracetam toxicity
por: Bou Nasif, Mei, et al.
Publicado: (2021)

Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register
por: Wieshmann, Udo Carl, et al.
Publicado: (2013)

Creatine phosphokinase elevation exacerbated by levetiracetam therapy
por: Isaacson, Julia E., et al.
Publicado: (2014)

B cell aplasia and hypogammaglobulinemia associated with levetiracetam
por: Ozdemir, Hulya, et al.
Publicado: (2018)

Levetiracetam for the treatment of myoclonic neurotoxicity induced by amiodarone
por: Celli, Diego, et al.
Publicado: (2020)

Levetiracetam/midazolam: Lack of efficacy: case report
Publicado: (2021)

Levetiracetam-Induced Psychosis in the Setting of Intracranial Cavernomas
por: Majarwitz, Daniel, et al.
Publicado: (2022)

Levetiracetam/topiramate: Drug ineffective: case report
Publicado: (2022)

Atypical, Levetiracetam-induced Hypersensitivity Syndrome Complicated by Fulminant Liver Failure in a Patient Undergoing Hemodialysis
por: Sato, Hirotaka, et al.
Publicado: (2022)

A case of glossopharyngeal neuralgia successfully treated with levetiracetam
por: Nishie, Hiroyuki, et al.
Publicado: (2023)

A case of rhabdomyolysis in which levetiracetam was suspected as the cause
por: Akiyama, Hisanao, et al.
Publicado: (2014)

Levetiracetam as a First-line Agent for Neonatal Seizure
por: Mandal, Anirban, et al.
Publicado: (2017)

Levetiracetam improves disinhibitory behavior in nonconvulsive status epilepticus
por: Yamamuro, Kazuhiko, et al.
Publicado: (2014)

Probable levetiracetam-related serum alkaline phosphatase elevation
por: Xiong, Nian, et al.
Publicado: (2012)

Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014)

Effect of plasmapheresis on serum levels of clobazam, levetiracetam and topiramate
por: Hau Man, To Harmony, et al.
Publicado: (2017)

Levetiracetam/lorazepam/phenytoin: Lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_etlqpvosd5o38t0ms673vbgp01